Adma Biologics reported $70.08M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Adma Biologics USD 70.08M 3.32M Sep/2025
Alnylam Pharmaceuticals USD 1.04B 13.75M Sep/2025
Dynavax Technologies USD 220.97M 214K Sep/2025
Takeda JPY 4.27T 81.29B Dec/2025